Continuing a whirlwind of recent deals, probably meant to mask serious issues, Centene has made a significant investment in RxAdvance, a supposedly futuristic PBM, with the right to increase its stake in the future.
https://www.prnewswire.com/news-releases/centene-and-rxadvance-establish-transformative-partnership-to-create-next-generation-pharmacy-management-solution-300612797.htmlA recent Gorman Health report describes the state of the Medicare Advantage market following the recent annual enrollment period.
Read More
Medial Early Sign, an Israeli firm that uses machine learning to improve patient care management, raises $30 million in new funding.
A study in the Journal of the American Medical Association confirms that the primary cause of greater health spending in the US than in other countries is high prices.
Read More
A study suggests flaws in Medicare's value-based purchasing program component relating to average beneficiary spending.
Read More
Study in Health Affairs suggests little benefit flows from community health improvement programs.
Read More
A poll from the University of Michigan finds that many consumers believe doctors deliver unnecessary care.
Read More